Published in Stem Cells Dev on December 01, 2008
Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal (2011) 3.31
Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med (2012) 1.92
Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med (2012) 1.41
Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int (2012) 1.20
Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev (2013) 1.14
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy. Curr Pharm Des (2013) 1.13
Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy. World J Stem Cells (2010) 1.09
Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. ScientificWorldJournal (2012) 1.09
Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone. Stem Cells (2011) 1.07
Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells. Front Immunol (2015) 1.06
Clinical grade adult stem cell banking. Organogenesis (2009) 1.03
Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells. Tissue Eng Part A (2010) 1.03
Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation (2012) 1.01
Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications. Stem Cells Transl Med (2014) 1.00
Comprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation. Stem Cells Int (2012) 0.99
Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int J Cell Biol (2009) 0.99
Long-term cultured human term placenta-derived mesenchymal stem cells of maternal origin displays plasticity. Stem Cells Int (2012) 0.99
Activity of mesenchymal stem cells in therapies for chronic skin wound healing. Organogenesis (2013) 0.96
Intracellular trafficking and endocytosis of CXCR4 in fetal mesenchymal stem/stromal cells. BMC Cell Biol (2014) 0.96
Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis. Stem Cell Reports (2014) 0.94
Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure. BMC Med (2012) 0.93
Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro. Clin Exp Immunol (2012) 0.92
Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med (2012) 0.92
Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS One (2012) 0.91
Transcriptomic portrait of human Mesenchymal Stromal/Stem Cells isolated from bone marrow and placenta. BMC Genomics (2014) 0.90
Collecting duct-derived cells display mesenchymal stem cell properties and retain selective in vitro and in vivo epithelial capacity. J Am Soc Nephrol (2014) 0.90
Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials. Stem Cell Res Ther (2014) 0.89
Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential. Stem Cells Int (2013) 0.88
Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1-42-infused mouse model of Alzheimer's disease. Cell Death Dis (2013) 0.87
High incidence of contaminating maternal cell overgrowth in human placental mesenchymal stem/stromal cell cultures: a systematic review. Stem Cells Transl Med (2014) 0.85
Stem cell transplantation for neuroprotection in stroke. Brain Sci (2013) 0.85
Points to Consider in Designing Mesenchymal Stem Cell-Based Clinical Trials. Transfus Med Hemother (2008) 0.84
Molecular and cellular characteristics of human and non-human primate multipotent stromal cells from the amnion and bone marrow during long term culture. Stem Cell Res Ther (2015) 0.82
Amniotic mesenchymal stem cells: a new source for hepatocyte-like cells and induction of CFTR expression by coculture with cystic fibrosis airway epithelial cells. J Biomed Biotechnol (2012) 0.82
Epigenetic Alterations of IL-6/STAT3 Signaling by Placental Stem Cells Promote Hepatic Regeneration in a Rat Model with CCl4-induced Liver Injury. Int J Stem Cells (2015) 0.81
An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside. J Clin Med (2013) 0.80
Derivation of mesenchymal stromal cells from canine induced pluripotent stem cells by inhibition of the TGFβ/activin signaling pathway. Stem Cells Dev (2014) 0.80
Dexamethasone and azathioprine promote cytoskeletal changes and affect mesenchymal stem cell migratory behavior. PLoS One (2015) 0.80
Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele. Stem Cells Transl Med (2015) 0.79
Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta. Stem Cells Dev (2013) 0.79
Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental Cells. Stem Cells Transl Med (2015) 0.78
Ectopic Bone Formation by Mesenchymal Stem Cells Derived from Human Term Placenta and the Decidua. PLoS One (2015) 0.78
Microarc-oxidized titanium surfaces functionalized with microRNA-21-loaded chitosan/hyaluronic acid nanoparticles promote the osteogenic differentiation of human bone marrow mesenchymal stem cells. Int J Nanomedicine (2015) 0.78
Human placenta mesenchymal stem cells expressing exogenous kringle1-5 protein by fiber-modified adenovirus suppress angiogenesis. Cancer Gene Ther (2014) 0.78
Human Mesenchymal Stromal Cells from Different Sources Diverge in Their Expression of Cell Surface Proteins and Display Distinct Differentiation Patterns. Stem Cells Int (2015) 0.77
Cellular therapy for repair of cardiac damage after acute myocardial infarction. Int J Cell Biol (2009) 0.77
Human term placental cells: phenotype, properties and new avenues in regenerative medicine. Int J Mol Cell Med (2012) 0.77
Stem cell-like dog placenta cells afford neuroprotection against ischemic stroke model via heat shock protein upregulation. PLoS One (2013) 0.77
Human Decidua-Derived Mesenchymal Cells Are a Promising Source for the Generation and Cell Banking of Human Induced Pluripotent Stem Cells. Cell Med (2012) 0.77
From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T. Stem Cell Rev (2013) 0.77
Differentiation of adipocytes and osteocytes from human adipose and placental mesenchymal stem cells. Iran J Basic Med Sci (2015) 0.77
Amniotic fluid stem cells and their application in cell-based tissue regeneration. Int J Fertil Steril (2012) 0.77
Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis. Stem Cell Res Ther (2016) 0.76
Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues. Stem Cell Rev (2015) 0.76
Fetal endothelial and mesenchymal progenitors from the human term placenta: potency and clinical potential. Stem Cells Transl Med (2015) 0.76
Comparison of the depolarization response of human mesenchymal stem cells from different donors. Sci Rep (2015) 0.75
Multipotent human stromal cells isolated from cord blood, term placenta and adult bone marrow show distinct differences in gene expression pattern. Genom Data (2014) 0.75
Bone marrow-derived mesenchymal stromal cells differ in their attachment to fibronectin-derived peptides from term placenta-derived mesenchymal stromal cells. Stem Cell Res Ther (2016) 0.75
Stem cells in dermatology. An Bras Dermatol (2014) 0.75
Isolation and Expansion of Mesenchymal Stem/Stromal Cells Derived from Human Placenta Tissue. J Vis Exp (2016) 0.75
Establishment of a xeno-free culture system that preserves the characteristics of placenta mesenchymal stem cells. Cytotechnology (2014) 0.75
A biotherapy based on PSCs-in-3D spheroid-ameliorated biologics depletes in vivo cancer-sustaining stem cells. Oncotarget (2015) 0.75
Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action. Int J Mol Sci (2017) 0.75
Packed Bed Bioreactor for the Isolation and Expansion of Placental-Derived Mesenchymal Stromal Cells. PLoS One (2015) 0.75
Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer. J Diabetes Res (2017) 0.75
Insights into the human mesenchymal stromal/stem cell identity through integrative transcriptomic profiling. BMC Genomics (2016) 0.75
Amelioration of experimental autoimmune encephalomyelitis through transplantation of placental derived mesenchymal stem cells. Sci Rep (2017) 0.75
Poly-L-lysine Prevents Senescence and Augments Growth in Culturing Mesenchymal Stem Cells Ex Vivo. Biomed Res Int (2016) 0.75
Different characteristics of mesenchymal stem cells isolated from different layers of full term placenta. PLoS One (2017) 0.75
Decellularized extracellular matrices produced from immortal cell lines derived from different parts of the placenta support primary mesenchymal stem cell expansion. PLoS One (2017) 0.75
Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3. Stem Cell Reports (2017) 0.75
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant (2005) 2.82
CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol (2002) 2.45
Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol (2003) 2.38
Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev (2008) 2.24
Chips with everything: DNA microarrays in infectious diseases. Lancet Infect Dis (2004) 1.87
The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc Natl Acad Sci U S A (2005) 1.80
Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol (2007) 1.52
Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak. J Clin Microbiol (2012) 1.48
Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities. Stem Cell Res (2011) 1.45
Causes of death and associated conditions (Codac): a utilitarian approach to the classification of perinatal deaths. BMC Pregnancy Childbirth (2009) 1.43
Anti-tumour necrosis factor-alpha treatment for perianal Crohn's disease in Australia. Med J Aust (2010) 1.39
A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care. Support Care Cancer (2008) 1.39
Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Br J Haematol (2008) 1.39
Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures. Cell Transplant (2009) 1.38
An evaluation of classification systems for stillbirth. BMC Pregnancy Childbirth (2009) 1.37
Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit Care (2011) 1.26
Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease. Nephrology (Carlton) (2007) 1.12
Four modes of adhesion are used during Helicobacter pylori binding to human mucins in the oral and gastric niches. Helicobacter (2008) 1.09
Clonal isolation and characterization of bone marrow stromal cells from patients with osteoarthritis. Tissue Eng (2007) 1.06
Common chromosomal fragile site FRA16D mutation in cancer cells. Hum Mol Genet (2005) 1.00
Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int J Cell Biol (2009) 0.99
Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species. Hum Mol Genet (2010) 0.98
Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue. Stem Cells Dev (2013) 0.95
Regional ventilation distribution in non-sedated spontaneously breathing newborns and adults is not different. Pediatr Pulmonol (2009) 0.90
Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein. Int J Gynecol Pathol (2005) 0.89
Micromarrows--three-dimensional coculture of hematopoietic stem cells and mesenchymal stromal cells. Tissue Eng Part C Methods (2012) 0.89
Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines. Cancer Genet Cytogenet (2005) 0.88
Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. Transplantation (2008) 0.88
A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors. Stem Cells Dev (2010) 0.86
Examination of the regulatory frameworks applicable to biologic drugs (including stem cells and their progeny) in Europe, the U.S., and Australia: part I--a method of manual documentary analysis. Stem Cells Transl Med (2012) 0.84
Points to Consider in Designing Mesenchymal Stem Cell-Based Clinical Trials. Transfus Med Hemother (2008) 0.84
Public access defibrillation: psychological consequences in responders. Resuscitation (2008) 0.83
Evaluation of methods for cultivating limbal mesenchymal stromal cells. Cytotherapy (2012) 0.83
A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer. J Immunother (2015) 0.83
Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease. Haematologica (2010) 0.82
Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach. J Paediatr Child Health (2011) 0.82
Manufacturing and use of human placenta-derived mesenchymal stromal cells for phase I clinical trials: establishment and evaluation of a protocol. Vojnosanit Pregl (2014) 0.81
The ascorbic acid paradox. Biochem Biophys Res Commun (2010) 0.81
Does lactate level in the first 12 hours of life predict mortality in extremely premature infants? J Paediatr Child Health (2009) 0.81
A flow cytometry based assay for the enumeration of regulatory T cells in whole blood. J Immunol Methods (2012) 0.81
Examination of the regulatory frameworks applicable to biologic drugs (including stem cells and their progeny) in Europe, the U.S., and Australia: part II--a method of software documentary analysis. Stem Cells Transl Med (2012) 0.81
Membrane bioreactors enhance microenvironmental conditioning and tissue development. Tissue Eng Part C Methods (2010) 0.79
Bioreactor for blood product production. Cell Transplant (2012) 0.78
Manufacture of clinical grade human placenta-derived multipotent mesenchymal stromal cells. Methods Mol Biol (2011) 0.78
Cellular therapy for repair of cardiac damage after acute myocardial infarction. Int J Cell Biol (2009) 0.77
Phase unwrapping algorithms for use in a true real-time optical body sensor system for use during radiotherapy. Appl Opt (2011) 0.77
Biological diversity from a structurally diverse library: systematically scanning conformational space using a pyranose scaffold. J Med Chem (2010) 0.76
The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. J Pain Symptom Manage (2010) 0.75
Dendritic cells in leukemia and lymphoma. Leuk Lymphoma (2006) 0.75
Out on her own. Midwives (2010) 0.75
Neurodevelopmental outcome and risk factors for disability for twin-twin transfusion syndrome treated with laser surgery. Am J Obstet Gynecol (2010) 0.75
Africa afresh. Midwives (2011) 0.75
No room for complacency. Midwives (2011) 0.75
Barriers to the best care of the dying in Queensland, Australia. J Palliat Med (2008) 0.75
Radio active. Midwives (2014) 0.75
Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach. Pathology (2010) 0.75
Tread carefully. Midwives (2011) 0.75
GPs should take annual health checks for people with learning difficulties seriously. BMJ (2011) 0.75
Like-minded fellow. Midwives (2011) 0.75
Breast is best ... until when? Midwives (2011) 0.75
More input for a growing problem. Midwives (2010) 0.75
Development of myocardial constructs using modulus-matched acrylated polypropylene glycol triol substrate and different nonmyocyte cell populations. Tissue Eng Part A (2011) 0.75
Reaching out. Midwives (2014) 0.75
A test of temperament. Midwives (2011) 0.75